Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Artificial Intelligence, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window.
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Artificial Intelligence, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. The average consequence score is 6, matching the 6 beat baseline for this window. Ashwini Vaishnaw appears in 1 tracked Biotech story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ashwini Vaishnaw. Shared-story counts are live from our verified record — not editorial picks.
At the India AI Impact Summit 2026, Minister Ashwini Vaishnaw highlighted a growing global consensus on mitigating AI risks while prioritizing healthcare as a core sector for AI deployment. This shift signals a move toward impact-driven, regulated AI applications that could transform drug discovery and diagnostics.
Source: moneycontrol.com · businesstoday.in
Ashwini Vaishnaw is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
